Drug Shortage Report for TEVA-MOXIFLOXACIN

Last updated on 2020-11-26 History
Report ID 128603
Drug Identification Number 02375702
Brand name TEVA-MOXIFLOXACIN
Common or Proper name TEVA-MOXIFLOXACIN 400MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MOXIFLOXACIN
Strength(s) 400MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-18
Estimated end date 2021-01-31
Actual end date
Shortage status Actual shortage
Updated date 2020-11-26
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-11-26 French Compare
v3 2020-11-26 English Compare
v2 2020-11-19 French Compare
v1 2020-11-19 English Compare